Credit Suisse’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Credit Suisse’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-152,295	Closed	-$5.54M	–	4265
2016 Q4	$5.54M	Buy	+152,295	New	+$5.39M	0.01%	1576

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Credit Suisse's CLCD Position: Q1 2017 in Review

Credit Suisse sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 152,295 shares — an estimated $5.54M sold.

Credit Suisse first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $5.54M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Credit Suisse reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Credit Suisse sold 152,295 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $5.54M.
Credit Suisse first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
Credit Suisse's CoLucid Pharmaceuticals, Inc. position peaked at $5.54M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.